Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries

American Journal of Hematology

Volumn 58, Issue 3, 1998, Pages 189-194

  Wada, Hideo ^a   Mori, Yoshitaka ^b   Shimura, Minori ^a   Hiyoyama, Katzuyo ^a   Ioka, Mika ^a   Nakasaki, Takahiro ^a   Nishikawa, Masakatsu ^a   Nakano, Masahiko ^c   Kumeda, Kousuke ^d   Kaneko, Toshihiro ^a   Nakamura, Shin ^e   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b Mie Red Cross Blood Center   (Japan)

^c MITSUBISHI GAS CHEMICAL COMPANY INC   (Japan)

^d KAKETSUKEN   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

DIC; Outcome of systemic vascular endothelial cell Injuries; Thrombomodulin; TTP

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; D DIMER; FIBRIN MONOMER; FIBRINOGEN; GABEXATE MESILATE; PLASMIN; PROTEIN C; STEROID; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; THROMBOPLASTIN;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOLYTIC UREMIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PARTIAL THROMBOPLASTIN TIME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; ANTITHROMBINS; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTHELIUM, VASCULAR; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; PLASMIN; PROTEIN C; PROTHROMBIN TIME; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SURVIVAL RATE; THROMBOMODULIN;

EID: 17944386474     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199807)58:3<189::AID-AJH5>3.0.CO;2-N     Document Type: Article

References (24)

1. Bick RL: Disseminated intravascular coagulation and related syndromes: A clinical review. Semin Thromb Hemost 14:299-338, 1988.
2. Muller-Berghaus G: Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemost 19:58-98, 1989.
3. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H, the Mie DIC study group: Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 74:848-852, 1995.
4. Bukousky RM: Thrombotic thrombocytopenic purpura. A review. Prog Hemost Thromb 6:287-337, 1982.
5. Byrness JJ, Moake JL: Thrombotic thrombocytopenic purpura, an haemolytic uraemic syndrome: Evolving concepts of pathogenesis and therapy. Clin Haematol 15:413-442, 1986.
6. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA, and The Canadian Apheresis Study Group: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393-395, 1991.
7. Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi K, Shirakawa S, Hayashi T, Suzuki K: Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation. Am J Hematol 44:85-88, 1993.
8. Wada H, Ohiwa M, Kaneko T, Tamaki S, Tanigawa M, Shirakawa S, Koyama M, Hayashi T, Suzuki K: Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 39:20-24, 1992.
9. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T, Shirakawa S: Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol 44:101-105, 1993.
10. Kobayashi N, Maegawa T, Takada M, Tanaka H, Gonmori H: Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 49:265-275, 1987.
11. Ohno H, Kambayashi J, Chang SW, Kosaki G: FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor: II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin. Thromb Res 24:445-452, 1980.
12. Wada H, Tomeoku M, Deguchi A, Suzuki H, Mori Y, Ito M, Deguchi K, Shirakawa S: Anticoagulant activity in cell homogenate of adult T cell leukemia. Thromb Haemost 59:197-201, 1988.
13. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama kazuyo, Nagaya S, Deguchi H, Mori Y, Kaneko T, Deguchi K, Fujii J, Shiku H: Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 51:255-260, 1996.
14. Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi A, Mori Y, Deguchi K, Shirakawa S, Suzuki K: Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 43:190-194, 1993.
15. Sumida Y, Wada H, Fujii M, Mori Y, Nakasaki T, Shimura M, Hiyoyama K, Yano Y, Deguchi H, Shiku H, Adachi Y: Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. Blood Coagl Fibrinolysis 8:303-307, 1997.
16. Wada H, Mori Y, Kaneko T, Wakita Y, Nakase T, Minamikawa K, Ohiwa M, Tamaki S, Tanigawa M, Kageyama S, Deguchi K, Nakano T, Shirakawa S, Suzuki K: Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. Am J Hematol 44:112-116, 1993.
17. Takagi M, Wada H, Mukai K, Kihira H, Yano S, Minamikawa K, Wakita Y, Nakase T, Nagaya S, Deguchi K, Shirakawa S, Suzuki K: Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis. Blood Coagl Fibrinolysis 5:713-717, 1994.
18. Rubli E: Plasma fibronectin and associated variables in surgical care patients. Ann Surg 197:310-, 1983.
19. Bauer KA, Kass BL, Beeler DL, et al.: Detection of protein C activation in humans. J Clin Invest 74:2033, 1984.
20. Buller HR, Ten Cate JW: Acquired antithrombin III deficiency: Laboratory diagnosis, incidence, clinical implication, and treatment with 3 antithrombin III concentrate. Am J Med 87:3B44S-3B48S, 1989.
21. Uchiba M, Okajima K, Murakami K, et al.: Endotoxin induced pulmonary vascular injury is mainly mediated by activated leukocytes in rats. Thromb Res 78:117, 1995.
22. Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Kaneko T, Ohiwa M, Deguchi K, Shirakawa S: Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 45:232-236, 1994.
23. Nemerson Y: Tissue factor and hemostasis. Blood 71:1-8, 1988.
24. Higure A, Okamoto K, Hirata K, Torodoki H, Nagafuchi Y, Takeda S, Katoh H, Itoh H, Ohsato K, Nakamura S: Macrophages and neutrophiles infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb Haemost 75:791-795, 1996.